Natumin Pharma AB is a Swedish AB based in Habo, operating in the Manufacture of perfume and toilet preparations sector. Incorporated in 1993, the company has 24 employees and reported revenue of SEK 67.1m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva produktion av- och handel med medicintekniska produkter, kosmetika, kosttillskott och dryck samt därmed förenlig verksamhet. Bolaget skall även bedriva produktutveckling inom sina verksamhetsområden.
In its most recent annual report (2024), Natumin Pharma AB reported revenue of SEK 67.1m, a decrease of 1% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of SEK 870.0k, and the EBITDA margin stood at -4.9%.
At the end of 2024, equity financed 21.9% of the balance sheet, and current assets covered short-term debt 2.3 times.
Frequently asked questions
What is the Org number of Natumin Pharma AB?
Natumin Pharma AB is registered with Bolagsverket / SCB under Org 5564747748.
What is the revenue of Natumin Pharma AB?
Natumin Pharma AB reported revenue of SEK 67.1m in 2024.
How many employees does Natumin Pharma AB have?
Natumin Pharma AB employs 24 people as of the latest annual report.
Who is the CEO of Natumin Pharma AB?
Stig Rikard Westrin is the CEO of Natumin Pharma AB, in role since 2022.
Who is the chairman of Natumin Pharma AB?
Marcus Stenkil chairs the board of Natumin Pharma AB, in role since 2025.
Where is Natumin Pharma AB headquartered?
Natumin Pharma AB's registered address is Snickaregatan 10.
